LUPIN / NSE / Biotechnology & Drugs

Lupin

INR 2,267.7-25.60 (0.72%) 1D

Last updated: 2026-06-16T05:21:36.984681+00:00

Price Chart

1Y Price Trend

Open1,999.6

High2,494

Low1,836.8

Close2,273.1

Volume6,96,820

Change273.5

Change %13.68%

Key Information

Ticker SymbolLUPIN

Current Price2,267.7

52-Week High2,494

52-Week Low1,836.8

Market Cap1.04 L

Beta0.52

Volume6,96,820

ISININE326A01037

Day High2,304

Day Low2,261.1

Open2,296.9

Recommendations

RatingHold

Target High2,492

Target Low1,838.65

Target Mean2.67

Target Median8.33

Risk Metrics

Overall RiskModerate risk

Board Risk20.55

Key Analysis

Overall score, performance score, return rating, defensive, aggressive, and balanced views.

Download app

Projection Analytics

Best-case, base-case, worst-case, and dynamic AI projection views.

Download app

News

Latest stock news

Add Lupin Ltd for the Target Rs.2,630 by Choice Institutional Equities - Investment Guru6 days ago

Market news

Add Lupin Ltd for the Target Rs.2,630 by Choice Institutional Equities Investment Guru

Lupin Ltd stock (INE326A01037): solid Q4 results keep pharma specialist in focus - AD HOC NEWS6 days ago

Market news

Lupin Ltd stock (INE326A01037): solid Q4 results keep pharma specialist in focus AD HOC NEWS

Lupin Ltd stock (INE326A01037): Fresh quarterly results keep pharma player in focus - AD HOC NEWS6 days ago

Market news

Lupin Ltd stock (INE326A01037): Fresh quarterly results keep pharma player in focus AD HOC NEWS

Lupin Partners with Spain’s ERN to Expand Access to Respiratory Therapy - Machine Maker8 days ago

Market news

Lupin Partners with Spain’s ERN to Expand Access to Respiratory Therapy Machine Maker

Lupin partners with LABORATORIOS ERN to launch Luforbec in Spain - Indian Pharma Post8 days ago

Market news

Lupin partners with LABORATORIOS ERN to launch Luforbec in Spain Indian Pharma Post

FDA approves Lupin's Lucentis biosimilar injection - Eyes On Eyecare8 days ago

Market news

FDA approves Lupin's Lucentis biosimilar injection Eyes On Eyecare

Lupin partners with Spanish pharma company for launch of Luforbec inhalers in Spain; check stock performance - Upstox9 days ago

Market news

Lupin partners with Spanish pharma company for launch of Luforbec inhalers in Spain; check stock performance Upstox

Lupin partners with Spanish pharma company Laboratorios ERN on respiratory drug, for Spain - BusinessLine9 days ago

Market news

Lupin partners with Spanish pharma company Laboratorios ERN on respiratory drug, for Spain BusinessLine